SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Follow-up) — Benny Leonard — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientBenny Leonard
Date of birth1896-04-07
IdentifiersMRN HR-BX008-SYN-TD; SSN (made up) 000-08-4106
Document date1946-08-25
AuthorMiriam Okafor-Rosenthal, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Fifteen-week review: blood pressure on the new medicines, kidney function and the sick visit. [S]

History of Present Illness

Mr. Leonard returns four weeks after the preventive visit, when losartan-hydrochlorothiazide was replaced by losartan 100 mg and amlodipine 5 mg after an episode of volume depletion in the July heat. He has had no lightheadedness since, and he drinks water between bouts and carries the sick-day card. He has refereed full cards every week without chest tightness or breathlessness, including two hot nights. His home readings over the past week averaged 122/76 mmHg. He has slight ankle puffiness at the end of a fight night that is gone by morning. His HIV and hepatitis C tests were negative and the hepatitis B panel showed no immunity; his stool test for colon cancer was negative. He says the money worry is less now that he is working steadily. [S]

ElementDetail
Home blood pressureAverage 122/76 mmHg over seven days
Kidney functionCreatinine 1.02 mg/dL, potassium 4.4 mmol/L, four weeks after the change
ScreeningHIV and hepatitis C negative; hepatitis B not immune; FIT negative

Review of Systems

SystemResultFinding
CardiovascularPositiveSlight ankle puffiness at the end of fight nights; no chest tightness, palpitations or fainting
ConstitutionalNegativeNo lightheadedness or tiredness
RespiratoryNegativeNo breathlessness at work

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Losartan 50 mg with hydrochlorothiazide 12.5 mg, one tablet each morningOne tablet each morningOral route1946-05-12 to 1946-06-30completedS
Losartan 100 mg with hydrochlorothiazide 25 mg, one tablet each morningOne tablet each morning; held from the sick visit; stopped at the preventive visitOral route1946-06-30 to 1946-07-28stoppedS
Atorvastatin 40 mg tablet, one each eveningOne tablet each eveningOral route1946-05-26activeS
Losartan 100 mg tablet, one each morningOne tablet each morning; hold on sick daysOral route1946-07-28activeS
Amlodipine 5 mg tablet, one each morningOne tablet each morningOral route1946-07-28activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1946-08-25Body height165cmS
1946-08-25Body weight73.4kgS
1946-08-25Body mass index (BMI) [Ratio]27kg/m2S
1946-08-25Systolic blood pressure124mm[Hg]S
1946-08-25Diastolic blood pressure78mm[Hg]S
1946-08-25Heart rate68/minS
1946-08-25Respiratory rate14/minS
1946-08-25Body temperature36.6CelS
1946-08-25Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1946-08-25Sodium [Moles/volume] in Serum or Plasma140mmol/L135-146 mmol/LNormalS
1946-08-25Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.3 mmol/LNormalS
1946-08-25Urea nitrogen [Mass/volume] in Serum or Plasma15mg/dL7-25 mg/dLNormalS
1946-08-25Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.7-1.3 mg/dLNormalS
1946-08-25Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1941)/1.73 sq M88mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1946-08-25Glucose [Mass/volume] in Serum or Plasma93mg/dL65-99 mg/dLNormalS

Physical Exam

Vital signs recorded on 1946-08-25; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 124/78 mmHg, pulse 68; weight 73.4 kg; no orthostatic fall
CardiovascularRegular rhythm; fourth heart sound softer; no murmur; trace ankle edema

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness and tightness across the chest on exertion for about two months, late in long nights of refereeing in hot arenas, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling; cause under evaluation with a cardiology consultationresolvedconfirmed R06.09S — Synthetic presenting problem anchored to his documented work as a referee; superseded at the consultation when stress testing showed no ischemia and the symptom was attributed to hypertensive heart disease.
Stage 2 hypertension found at a yearly fitness examination for his referee's license (164/100 and 160/98 mmHg), with left ventricular hypertrophy by voltage on the ECG; untreated; home readings to followresolvedconfirmed I10S — Synthetic diagnosis at intake; reclassified as hypertensive heart disease after the echocardiogram at the consultation.
Hypertensive heart disease without heart failure: concentric left ventricular hypertrophy (septum 13 mm, mass index 118 g/m2) with normal ejection fraction, grade 1 diastolic dysfunction, a mildly enlarged left atrium and an exaggerated blood pressure rise on exercise; no features of hypertrophic cardiomyopathyactiveconfirmed I11.9S — Synthetic diagnosis made at the cardiology consultation; not a claim about his real heart.
Coronary atherosclerosis found by coronary calcium scoring (Agatston score 186, about the 80th percentile for his age and sex), without angina and with no inducible ischemia on exercise stress echocardiographyactiveconfirmed I25.10S — Synthetic diagnosis made at the cardiology consultation; not a retrospective diagnosis of the cause of his death, which is disputed.
Hypercholesterolemia: LDL 160 mg/dL, HDL 44 mg/dL, lipoprotein(a) not raised; no diabetesactiveconfirmed E78.00S — Synthetic diagnosis at intake.
Volume depletion after refereeing a long card in a heat wave while taking losartan 100 mg with hydrochlorothiazide 25 mg: lightheaded on standing, with an orthostatic fall in blood pressure, a prerenal rise in creatinine to 1.44 mg/dL and potassium 3.3 mmol/L; no fainting, chest pain or arrhythmiaresolvedconfirmed E86.0S — Synthetic acute problem from the thiazide in summer heat; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationClinic blood pressure, average of two seated readingsEvery visitCompleted today124/78 mmHg
Self-managementHome blood pressure monitoring (validated upper-arm cuff), readings sent weeklyEvery day during titration; then a week before each visitCompleted todaySeven-day average 122/76 mmHg: at goal
LaboratoryBasic metabolic panel (sodium, potassium, creatinine, eGFR)Two to four weeks after starting or changing an ARB or diuretic; then every six monthsDeferredThe panel ordered two weeks after the dose increase at the seven-week visit was not drawn: he was refereeing four nights that week, and no reminder call was made. The next check was at the sick visit three weeks after the increase, during volume depletion in a heat wave (creatinine 1.44 mg/dL, potassium 3.3 mmol/L), which recovered within a week. An earlier check would probably have been normal and would not have prevented the heat-related episode, but a fall in potassium on the higher thiazide dose could have been found sooner. Corrective action: a standing laboratory order with a reminder call for every check after a medication change
LaboratoryBasic metabolic panel (sodium, potassium, creatinine, eGFR), after the change to losartan and amlodipineTwo to four weeks after a changeCompleted todaySodium 140, potassium 4.4 mmol/L, creatinine 1.02 mg/dL, eGFR 88
LaboratoryLipid panelFour to twelve weeks after starting a statin; then yearlyUp to dateLDL 66 mg/dL at nine weeks (preventive visit); next in a year
ExaminationFundoscopic examinationYearlyUp to dateMild arteriolar narrowing at the preventive visit
ExaminationSymptoms: exertional chest discomfort, breathlessness, palpitations, faintingEvery visitCompleted todayNone at full cards, including hot nights
ImagingEchocardiogramAt diagnosis of stage 2 hypertension or suspected hypertrophy; repeat in six to twelve months to judge regressionUp to dateRepeat due six to twelve months after the first
ExaminationWeight, BMI and physical activityEvery visitCompleted today73.4 kg, BMI 27.0
Medication safetyAdherence and side effects (cough, edema, muscle aches, lightheadedness)Every visitCompleted todayTrace ankle edema on amlodipine; no lightheadedness or muscle aches
Self-managementSick-day rulesWhen starting an ARB or diureticCompleted todayCarries the wallet card; knows to skip losartan on sick or very hot days without drinking
Self-managementReturn to work: refereeing, heat and hydration, warning symptoms, defibrillator at the venueBefore return to full exertion; then every visitCompleted todayFull cards weekly with water between bouts; the venue has a defibrillator at ringside

Goal progress:

Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 1 of 2, after a screening panel showed no immunity [S]

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (2026); Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension (2015); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and ischemic heart disease monographs (2026)

Follow-up: First hepatitis B vaccine dose today. Twenty-four-week review at the end of October with the second hepatitis B and zoster doses and the influenza vaccine. Next scheduled visit 1946-10-27: twenty-four-week review: blood pressure control, symptoms at work, mood and worry, aspirin, and the plan ahead. [S]